title: Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy.
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Thiem
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Mergler
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Hermann
authors.initials: H
authors.lastname: Kneitz
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Gerhard
authors.initials: G
authors.lastname: Weyandt
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Goebeler
authors.affiliation: Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Anja
authors.initials: A
authors.lastname: Gesierich
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology* / Q000517:prevention & control; D005260:Female; D017497:Hidradenitis Suppurativa / Q000139:chemically induced* / Q000473:pathology* / Q000517:prevention & control; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D012307:Risk Factors; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib